Delivery Order SPE2DR25D2012-SPE2DR26F1BLG
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,495.08 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract type. The order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,566.78 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packages) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive procurement executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,662.12 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) under a firm fixed-price contract. The award was made on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,585.67 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count units) under a firm fixed-price contract. The award was made on May 23, 2025, with an ultimate completion date of May 27, 2025, and was not set-aside for small business or other designated groups. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $13,867.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price delivery order, executed on December 4, 2025, with completion targeted for December 5, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency has awarded a delivery order valued at $12,658.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packaging). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The order...
- The Defense Logistics Agency awarded a delivery order valued at $5,744.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with the DLA. The product will be delivered to the company's headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $5,534.04 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packages) under a firm fixed-price contract. This non-set-aside award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,846.60 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025. The award was issued on September 23, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...